Teva to buy Allergan Generics for $40.5 billion
July 27, 2015 at 06:58 AM EDT
Teva is buying Allergan PLC’s generics unit for $40.5 billion in cash and stock, in a deal that will vault the Israeli company into the top ranks of global drug makers.
